pyridoxal phosphate has been researched along with Absence Status in 6 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine the prevalence of pyridoxine deficiency, measured by pyridoxal phosphate (PLP) levels, in patients admitted to the hospital with established (benzodiazepine-resistant) status epilepticus (SE) (eSE) and to compare to three control groups: intensive care unit (ICU) patients without SE (ICU-noSE), non-ICU inpatients without SE (non-ICU), and outpatients with or without a history of epilepsy (outpatient)." | 8.31 | Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus. ( Blodgett, C; Boudesseul, J; Bruzzone, MJ; Hianik, R; Hirsch, LJ; Jadav, R; Liu, C; Meeker, R; Olm-Shipman, C; Patel, P; Rubinos, C; Tsai, C; Wilson, SE; Zhu, H, 2023) |
| "Pyridoxine-dependent epilepsy (PDE) is a treatable inborn error of metabolism with autosomal recessive inheritance." | 7.77 | Status epilepticus in a neonate treated with pyridoxine because of a familial recurrence risk for antiquitin deficiency: pyridoxine toxicity? ( Fingerhut, M; Hartmann, H; Jakobs, C; Plecko, B, 2011) |
| "The objective of this study was to determine the prevalence of pyridoxine deficiency, measured by pyridoxal phosphate (PLP) levels, in patients admitted to the hospital with established (benzodiazepine-resistant) status epilepticus (SE) (eSE) and to compare to three control groups: intensive care unit (ICU) patients without SE (ICU-noSE), non-ICU inpatients without SE (non-ICU), and outpatients with or without a history of epilepsy (outpatient)." | 4.31 | Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus. ( Blodgett, C; Boudesseul, J; Bruzzone, MJ; Hianik, R; Hirsch, LJ; Jadav, R; Liu, C; Meeker, R; Olm-Shipman, C; Patel, P; Rubinos, C; Tsai, C; Wilson, SE; Zhu, H, 2023) |
| "To determine whether patients with pyridoxine-responsive seizures but normal biomarkers for antiquitin deficiency and normal sequencing of the ALDH7A1 gene may have PNPO mutations." | 3.80 | Pyridoxine responsiveness in novel mutations of the PNPO gene. ( Abela, L; Clayton, P; Connolly, M; Hasselmann, O; Hofer, D; Kanz, S; Maier, O; Mills, P; Paschke, E; Paul, K; Plecko, B; Schmiedel, G; Stockler, S; Struys, E; Wolf, N, 2014) |
| "Pyridoxine-dependent epilepsy (PDE) is a treatable inborn error of metabolism with autosomal recessive inheritance." | 3.77 | Status epilepticus in a neonate treated with pyridoxine because of a familial recurrence risk for antiquitin deficiency: pyridoxine toxicity? ( Fingerhut, M; Hartmann, H; Jakobs, C; Plecko, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Rubinos, C | 1 |
| Bruzzone, MJ | 1 |
| Blodgett, C | 1 |
| Tsai, C | 1 |
| Patel, P | 1 |
| Hianik, R | 1 |
| Jadav, R | 1 |
| Boudesseul, J | 1 |
| Liu, C | 1 |
| Zhu, H | 1 |
| Wilson, SE | 1 |
| Olm-Shipman, C | 1 |
| Meeker, R | 1 |
| Hirsch, LJ | 1 |
| Plecko, B | 2 |
| Paul, K | 1 |
| Mills, P | 1 |
| Clayton, P | 1 |
| Paschke, E | 1 |
| Maier, O | 1 |
| Hasselmann, O | 1 |
| Schmiedel, G | 1 |
| Kanz, S | 1 |
| Connolly, M | 1 |
| Wolf, N | 1 |
| Struys, E | 1 |
| Stockler, S | 1 |
| Abela, L | 1 |
| Hofer, D | 1 |
| Parikh, S | 1 |
| Hyland, K | 1 |
| Lachhwani, DK | 1 |
| Hartmann, H | 1 |
| Fingerhut, M | 1 |
| Jakobs, C | 1 |
| Yoshimura, K | 1 |
| Nakagawa, E | 1 |
| Tanaka, T | 1 |
| Ohno, M | 1 |
| Yamano, T | 1 |
| Shimada, M | 1 |
6 other studies available for pyridoxal phosphate and Absence Status
| Article | Year |
|---|---|
Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus.
Topics: Adult; Aged; Aged, 80 and over; Humans; Middle Aged; Prospective Studies; Pyridoxal; Pyridoxal Phosp | 2023 |
Pyridoxine responsiveness in novel mutations of the PNPO gene.
Topics: Aldehyde Dehydrogenase; Alleles; Animals; Brain Diseases, Metabolic; CHO Cells; Chromosome Deletion; | 2014 |
Vitamins, not surgery: spinal fluid testing in hemispheric epilepsy.
Topics: Aldehyde Dehydrogenase; Electroencephalography; Female; Folic Acid; Functional Laterality; Humans; I | 2009 |
Status epilepticus in a neonate treated with pyridoxine because of a familial recurrence risk for antiquitin deficiency: pyridoxine toxicity?
Topics: Adult; Aldehyde Dehydrogenase; Epilepsy; Female; Humans; Infant; Infant, Newborn; Infusions, Parente | 2011 |
A case of nonconvulsive status epilepticus associated with focal cortical dysplasia.
Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Brain Diseases; Cerebral Cortex; Child; Child | 2003 |
Efficacy of pyridoxal phosphate in treating an adult with intractable status epilepticus.
Topics: Adult; Anticonvulsants; Electroencephalography; Humans; Male; Pyridoxal Phosphate; Retreatment; Stat | 1997 |